Lista de obras -

A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder

artículo científico publicado en 2016

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

scientific article published on 04 January 2016

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

artículo científico publicado en 2014

Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine

artículo científico publicado en 2012

An examination of associations between the inability to taste phenylthiocarbamide (PTC) and clinical characteristics and trait markers in first-episode, nonaffective psychotic disorders

artículo científico publicado en 2013

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography ⬇️

artículo científico publicado en 2015

Becoming an Academic Researcher in Psychiatry: A View From the Trenches.

artículo científico publicado en 2016

Biomarkers in mood disorders research: developing new and improved therapeutics

artículo científico publicado en 2014

Classics in Chemical Neuroscience: Ketamine.

artículo científico publicado en 2017

Clinical predictors of ketamine response in treatment-resistant major depression

artículo científico publicado en 2014

Current Trends in Identifying Rapidly Acting Treatments for Depression

artículo científico publicado en 2016

Defining anxious depression: a review of the literature.

artículo científico publicado en 2013

Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants

artículo científico publicado en 2014

Do the dissociative side effects of ketamine mediate its antidepressant effects?

artículo científico publicado en 2014

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

artículo científico publicado en 2018

Drs Ionescu and Cusin Reply

artículo científico publicado en 2017

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

artículo científico

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression

artículo científico publicado en 2018

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

artículo científico publicado en 2013

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

artículo científico publicado en 2014

Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt

artículo científico publicado en 2014

Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

artículo científico publicado en 2014

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.

artículo científico publicado en 2018

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

artículo científico publicado en 2015

Major Depression Is Not Associated with Blunting of Aversive Responses; Evidence for Enhanced Anxious Anticipation ⬇️

artículo científico publicado el 8 de agosto de 2013

NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER.

artículo científico publicado en 2013

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study

artículo científico publicado en 2015

Neurobiology of anxious depression: a review

artículo científico publicado en 2013

Perinatal depressive symptoms often start in the prenatal rather than postpartum period: results from a longitudinal study

scientific article published on 04 February 2020

Pharmacologic treatment of dimensional anxious depression: a review

artículo científico publicado en 2014

Pharmacological approaches to the challenge of treatment-resistant depression

artículo científico publicado en 2015

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

artículo científico publicado en 2016

Recognition of emotional facial expressions in anxious and nonanxious depression.

artículo científico publicado en 2016

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial

artículo científico publicado en 2018

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

artículo científico publicado en 2014

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.

artículo científico publicado en 2013

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder

artículo científico publicado en 2013

Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression ⬇️

artículo científico publicado el 28 de mayo de 2013

Subtyping first‐episode non‐affective psychosis using four early‐course features: potentially useful prognostic information at initial presentation ⬇️

artículo científico publicado el 24 de enero de 2013

The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.

artículo científico publicado en 2017

Updates and trends in the treatment of major depressive disorder

artículo científico publicado en 2014

Ziprasidone augmentation for anxious depression

artículo científico publicado en 2016

Lista de obras de

A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine

An examination of associations between the inability to taste phenylthiocarbamide (PTC) and clinical characteristics and trait markers in first-episode, nonaffective psychotic disorders

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography ⬇️

Becoming an Academic Researcher in Psychiatry: A View From the Trenches.

Biomarkers in mood disorders research: developing new and improved therapeutics

Classics in Chemical Neuroscience: Ketamine.

Clinical predictors of ketamine response in treatment-resistant major depression

Current Trends in Identifying Rapidly Acting Treatments for Depression

Defining anxious depression: a review of the literature.

Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Drs Ionescu and Cusin Reply

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt

Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

Major Depression Is Not Associated with Blunting of Aversive Responses; Evidence for Enhanced Anxious Anticipation ⬇️

NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER.

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study

Neurobiology of anxious depression: a review

Perinatal depressive symptoms often start in the prenatal rather than postpartum period: results from a longitudinal study

Pharmacologic treatment of dimensional anxious depression: a review

Pharmacological approaches to the challenge of treatment-resistant depression

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

Recognition of emotional facial expressions in anxious and nonanxious depression.

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder

Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression ⬇️

Subtyping first‐episode non‐affective psychosis using four early‐course features: potentially useful prognostic information at initial presentation ⬇️

The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.

Updates and trends in the treatment of major depressive disorder

Ziprasidone augmentation for anxious depression